Evidence map›Paper›PMID 40983644›Full record

ArticleEuropean journal of human genetics : EJHG2026

Older research participants are motivated to receive genetic results for the benefit of younger relatives.

Amanda M Willis, Florence Chiew, Philomena Horsley, Sommon Klumsathian, Ezekiel Ling, Chris Jacobs, Paul Lacaze, Jane Tiller, Mary-Anne Young

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amanda M WillisClinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. a.willis@garvan.org.au.ORCID 0000-0002-1529-3833
Florence ChiewClinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Philomena HorsleyMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Sommon KlumsathianGraduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Ezekiel LingGraduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Chris JacobsGraduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.ORCID 0000-0002-9557-9080
Paul LacazeSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.ORCID 0000-0002-0902-6798
Jane Tiller *School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.ORCID 0000-0003-3906-6632
Mary-Anne Young *Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-2493-6394

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 2025900Department of Health | National Health and Medical Research Council (NHMRC) 2026325National Heart Foundation of Australia (Heart Foundation) 107157National Heart Foundation of Australia (Heart Foundation) 107171
6 · The paper itself

Abstract

The benefit of returning medically actionable genetic research findings is widely recognised. However, there is uncertainty regarding the return of results to older people (>70 years), given the reduced actionability in this age group. The goal of this study was to assess whether older people were motivated to receive genetic results, primarily for the benefit of younger relatives. Semi-structured interviews were conducted with individuals aged ≥70 enrolled in the ASPirin in Reducing Events in the Elderly (ASPREE) study. Participants received medically actionable genetic results in Hereditary Breast and Ovarian Cancer, Lynch syndrome or Familial Hypercholesterolaemia genes. Data were analysed using reflexive thematic analysis. Sixteen individuals were interviewed (mean age 82 years). While participants recognised the limited actionability of the genetic results for themselves, the perceived benefits for younger family members motivated them to receive genetic findings and share with relatives. Participants reported positive experiences of receiving genetic results, underpinned by their existing relationship with the ASPREE trial, and reported that their age promoted their adaptation to results. These findings illustrate positive impact from returning genetic research results to older research participants and suggest that older people desire genetic information to benefit their younger family members.

Indexed as

FamilyGenetic ResearchGenetic TestingMotivationResearch SubjectsAgedAged, 80 and overFemaleHumansMale

Identifiers

PMID40983644
PMCPMC13046791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.